NasdaqGM - Nasdaq Real Time Price USD
Zentalis Pharmaceuticals, Inc. (ZNTL)
1.2607
+0.0307
+(2.49%)
As of 11:11:52 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 9 |
| Avg. Estimate | -0.61 | -0.62 | -2.25 | -2.25 |
| Low Estimate | -0.69 | -1.09 | -3.07 | -3.27 |
| High Estimate | -0.52 | -0.44 | -1.75 | -1.27 |
| Year Ago EPS | 0.14 | -1.24 | -2.28 | -2.25 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 40.56M | -- | 67.42M | -- |
| Sales Growth (year/est) | -100.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.74 | -0.83 | -0.87 | -0.68 |
| EPS Actual | 0.14 | -1.24 | -0.56 | -0.61 |
| Difference | 0.88 | -0.41 | 0.31 | 0.07 |
| Surprise % | 118.85% | -49.95% | 35.69% | 9.96% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.61 | -0.62 | -2.25 | -2.25 |
| 7 Days Ago | -0.61 | -0.62 | -2.25 | -2.32 |
| 30 Days Ago | -0.66 | -0.69 | -2.46 | -2.35 |
| 60 Days Ago | -0.66 | -0.69 | -2.46 | -2.35 |
| 90 Days Ago | -0.8 | -0.81 | -2.93 | -2.63 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 3 |
| Up Last 30 Days | -- | -- | 2 | 3 |
| Down Last 7 Days | 2 | 1 | 4 | 4 |
| Down Last 30 Days | 2 | 1 | 4 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZNTL | -533.52% | 50.29% | 1.27% | 0.11% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Wedbush: Neutral to Neutral | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/30/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/29/2025 |
| Maintains | UBS: Neutral to Neutral | 1/28/2025 |
Related Tickers
BOLD Boundless Bio, Inc.
1.4300
-0.69%
ALXO ALX Oncology Holdings Inc.
0.4280
+1.35%
FDMT 4D Molecular Therapeutics, Inc.
3.3100
+7.47%
ORIC ORIC Pharmaceuticals, Inc.
5.34
+5.13%
PMVP PMV Pharmaceuticals, Inc.
0.8643
-2.09%
ALEC Alector, Inc.
1.2100
+3.42%
GBIO Generation Bio Co.
0.3900
+8.35%
ACRV Acrivon Therapeutics, Inc.
1.1750
+1.29%
MGNX MacroGenics, Inc.
1.5450
+8.04%
CRGX CARGO Therapeutics, Inc.
4.0800
+1.49%